DUBLIN--(BUSINESS WIRE)--The "Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Market Growth Opportunities, 2023" report has been added to ResearchAndMarkets.com's ...
Lonza launched its AI-enabled Route Scouting Service offering which is designed to streamline synthetic route identification for novel APIs by combining Lonza’s global chemical supply chain ...
WHITE PLAINS, N.Y.--(BUSINESS WIRE)--Oligomerix, Inc., a clinical-stage biotechnology company pioneering the development of a platform of tau self-association inhibitors for Alzheimer’s disease (AD) ...
One, an integrated platform combining high-throughput ADME testing with AI-powered human pharmacokinetic projections.
GSK said it is ending the development program for the small-molecule drug Belrestotug. The British pharmaceutical giant said Tuesday that the decision is based on a new interim analyses from phase 2 ...
As the science of drug discovery has grown in scale and gotten more complicated, so have the drug molecules themselves. But there’s a promising class of drugs made of just a handful of atoms that ...
Recurring stories and special news packages from C&EN. Not too long ago, these small-molecule drugs looked as if they were going out of fashion. Advances in biotechnology enabled pharmaceutical ...